Weight Loss
Trials of weight loss show little improvement in quality of life
Published in Drug Week, July 22nd, 2005
In a recent study, researchers in the United States conducted a study "to estimate the effect of weight-loss interventions on health-related quality of life (HrQoL) in randomized controlled trials (RCTs); to conduct a meta-analysis of weight-loss treatment on depressive symptoms; and to examine methodological and presentation issues that compromise study validity.
"We conducted a structured review of 34 RCTs with weight-loss interventions that reported the relationship between HrQoL and treatment at two or more time points....
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2005-07-22)
More Articles from Drug Week
- Drug Development
Allon files IND to begin clinical trials for second product AL-208 - Drug Development
Phase III trial of Neurodex initiated for diabetic neuropathic pain - HIV/AIDS Therapy
Company announces phase I/II clinical trial evaluating HIV integrase inhibitor - Hepatitis B Therapy
Alamifovir and its metabolites have positive pharmacokinetics in healthy men - Neuroblastoma
Fine tuning drug levels in neuroblastoma patients is effective, researchers show - AIDS-Related Kaposi Sarcoma
Docetaxel rapidly effective in anthracycline-pretreated AIDS-related KS patients - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
